BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Arpida Ltd. 

Dammstrasse 36

Munchenstein    4142  Switzerland
Phone: 41-61-417-9660 Fax: 41-61-417-9661


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Evolva SA Agrees to Reverse Merger with Arpida 9/11/2009 8:43:50 AM    More...
Arpida to Discuss Strategy With Shareholders 5/7/2009 11:48:23 AM    More...
Arpida Annual General Meeting of Shareholders Approves All Board Proposals 5/7/2009 11:16:34 AM    More...
Arpida Board Reviews Strategic Options to Present to Shareholders at Shareholders' Meeting 3/17/2009 10:33:06 AM    More...
Arpida Announces Full Year 2008 Financial Results 2/25/2009 11:26:00 AM    More...
FDA Issues Arpida Complete Response Letter for Iclaprim 1/20/2009 8:30:25 AM    More...
Arpida Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on iclaprim 11/18/2008 10:06:28 AM    More...
Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 10/27/2008 10:33:35 AM    More...
Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008 10/15/2008 11:48:58 AM    More...
Arpida Completes Enrollment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 9/24/2008 11:21:43 AM    More...
1234